Ripe for picking

Article Abstract:

The British government is supporting the case for genetically modified foods, and this is linked to the view that the biotechnology industry deserves support as an industry with potential. Germany has backed its biotechnology industry, and Britain is to some extent competing with Germany. Critics argue that many German biotech companies lack management expertise. Britain is likely to focus on existing companies rather than on creating new ones. Tax benefits for stock ownership schemes amy also be used as a way of attracting talent to the sector.

Biochemistry, Research and Development in the Physical, Engineering, and Life Sciences, Economic policy, Industrial policy

---

Ready for cloning: biotechnology in Britain

Article Abstract:

Several British biotechnology firms are following the lead of their US-based counterparts by raising large amounts of cash via the securities markets. Three UK genetic engineering enterprises, including Cantab Pharmaceuticals, will issue stock in the US NASDAQ market in Jul 1992.

---

Biorhythms

Article Abstract:

A British biotechnology firm got the London Stock Exchange to waive its rule to not list companies before they establish a three-year record of profits. Biotech companies are attracting investors because drug companies have not been performing well.

Laws, regulations and rules, London Stock Exchange PLC

Similar abstracts:

• Abstracts: Using EVA for acquisitions. Acquisitions. Acquisitions in Europe
• Abstracts: The revision thing. The vision thing. The fusion thing
• Abstracts: No time for planning. Enhancement in conservation areas. Managing old towns
• Abstracts: New factories for old. Tough at the top: Volkswagen. Lotus-eater: British sports cars

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.